ARCHIVES

FDA, NCI united in pursuit of 2015 goal, Andrew von Eschenbach tells cancer center directors; says his appointment was necessary to “maintain the momentum of the FDA.”

This article is from The Cancer Letter archive.

Vol. 31 No. 38 | October 21, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: GAO Probe Of Cancer Control Program Nears End; Renewal Bill Mark Up Not Before Oct. 22

October 12, 1979

NCI Issues Alert On Stage 2/3 Rectal Cancer Therapy

March 22, 1991

SPOREs hammer out research agenda, seek $50,000 from NCI for further tissue analysis.

April 30, 2004

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

November 22, 2006

Conversation with The Cancer Letter: McKinsey Charge: Create Plan To Expand MD Anderson’s Reach

February 7, 2014

ICCCR Issues RFP For Cancer Risk Scale

March 6, 1992